[tt] [silk] Treating the dead

[Eugen Leitl]

----- Forwarded message from Udhay Shankar N <udhay at pobox.com> -----

From: Udhay Shankar N <udhay at pobox.com>
Date: Wed, 23 Jan 2008 14:02:46 +0530
To: silklist at lists.hserus.net
Subject: [silk] Treating the dead
User-Agent: Thunderbird 2.0.0.9 (Windows/20071031)
Reply-To: silklist at lists.hserus.net

http://www.newsweek.com/id/35045

To Treat the Dead
The new science of resuscitation is changing the way doctors think about 
heart attacks—and death itself.

By Jerry Adler | Newsweek Web Exclusive

Consider someone who has just died of a heart attack. His organs are 
intact, he hasn't lost blood. All that's happened is his heart has 
stopped beating—the definition of "clinical death"—and his brain has 
shut down to conserve oxygen. But what has actually died?

As recently as 1993, when Dr. Sherwin Nuland wrote the best seller "How 
We Die," the conventional answer was that it was his cells that had 
died. The patient couldn't be revived because the tissues of his brain 
and heart had suffered irreversible damage from lack of oxygen. This 
process was understood to begin after just four or five minutes. If the 
patient doesn't receive cardiopulmonary resuscitation within that time, 
and if his heart can't be restarted soon thereafter, he is unlikely to 
recover. That dogma went unquestioned until researchers actually looked 
at oxygen-starved heart cells under a microscope. What they saw amazed 
them, according to Dr. Lance Becker, an authority on emergency medicine 
at the University of Pennsylvania. "After one hour," he says, "we 
couldn't see evidence the cells had died. We thought we'd done something 
wrong." In fact, cells cut off from their blood supply died only hours 
later.

But if the cells are still alive, why can't doctors revive someone who 
has been dead for an hour? Because once the cells have been without 
oxygen for more than five minutes, they die when their oxygen supply is 
resumed. It was that "astounding" discovery, Becker says, that led him 
to his post as the director of Penn's Center for Resuscitation Science, 
a newly created research institute operating on one of medicine's newest 
frontiers: treating the dead.

Biologists are still grappling with the implications of this new view of 
cell death—not passive extinguishment, like a candle flickering out when 
you cover it with a glass, but an active biochemical event triggered by 
"reperfusion," the resumption of oxygen supply. The research takes them 
deep into the machinery of the cell, to the tiny membrane-enclosed 
structures known as mitochondria where cellular fuel is oxidized to 
provide energy. Mitochondria control the process known as apoptosis, the 
programmed death of abnormal cells that is the body's primary defense 
against cancer. "It looks to us," says Becker, "as if the cellular 
surveillance mechanism cannot tell the difference between a cancer cell 
and a cell being reperfused with oxygen. Something throws the switch 
that makes the cell die."

With this realization came another: that standard emergency-room 
procedure has it exactly backward. When someone collapses on the street 
of cardiac arrest, if he's lucky he will receive immediate CPR, 
maintaining circulation until he can be revived in the hospital. But the 
rest will have gone 10 or 15 minutes or more without a heartbeat by the 
time they reach the emergency department. And then what happens? "We 
give them oxygen," Becker says. "We jolt the heart with the paddles, we 
pump in epinephrine to force it to beat, so it's taking up more oxygen." 
Blood-starved heart muscle is suddenly flooded with oxygen, precisely 
the situation that leads to cell death. Instead, Becker says, we should 
aim to reduce oxygen uptake, slow metabolism and adjust the blood 
chemistry for gradual and safe reperfusion.

Researchers are still working out how best to do this. A study at four 
hospitals, published last year by the University of California, showed a 
remarkable rate of success in treating sudden cardiac arrest with an 
approach that involved, among other things, a "cardioplegic" blood 
infusion to keep the heart in a state of suspended animation. Patients 
were put on a heart-lung bypass machine to maintain circulation to the 
brain until the heart could be safely restarted. The study involved just 
34 patients, but 80 percent of them were discharged from the hospital 
alive. In one study of traditional methods, the figure was about 15 percent.

Becker also endorses hypothermia—lowering body temperature from 37 to 33 
degrees Celsius—which appears to slow the chemical reactions touched off 
by reperfusion. He has developed an injectable slurry of salt and ice to 
cool the blood quickly that he hopes to make part of the standard 
emergency-response kit. "In an emergency department, you work like mad 
for half an hour on someone whose heart stopped, and finally someone 
says, 'I don't think we're going to get this guy back,' and then you 
just stop," Becker says. The body on the cart is dead, but its trillions 
of cells are all still alive. Becker wants to resolve that paradox in 
favor of life.

© 2007 Newsweek, Inc.

----- End forwarded message -----
-- 
Eugen* Leitl <a href="http://leitl.org">leitl</a> http://leitl.org
______________________________________________________________
ICBM: 48.07100, 11.36820 http://www.ativel.com http://postbiota.org
8B29F6BE: 099D 78BA 2FD3 B014 B08A  7779 75B0 2443 8B29 F6BE